Revive has a former FDA doctor on its side- a Doctor Boulevare if I remember correctly. Clearly, they relied on this individual to direct them with their endpoint adjustments. . Going against BMT does not make me happy, but if RVVT is "stacking the books" and picking Buccy's two best symptoms, so be it. Let's show the data and then if they want another endpoint, we can visit that .Hopefully, someone will take notice of the symptom reduction and we can move forward.
ps. If MF loves BMT so much to give him options, then he obviously values his opinion and to go against him, the data must be something special.
pps. Fingers crossed and hope the longs stay strong and the FDA comes to its senses.
News 
Market Data 
Discover 
AI
